Author information from the last article
E-post: mette.brekke@medisin.uio.no
Mette Brekke er spesialist i allmennmedisin og professor emerita ved Avdeling for allmennmedisin, Universitetet i Oslo.
Articles by Mette Brekke
Medical education and training during a pandemic
- Mette Brekke,
- Cathrine Ebbing,
- Torben Wisborg
05.08.2021:
The COVID-19 pandemic has turned medical education and training into lonely online studies. How can we ensure that the medical students still become fully fledged doctors? At this time, new cohorts of medical students are starting their studies here in Norway and abroad. We have put behind us a...
Poisonings by substances of abuse at the Oslo Accident and Emergency Outpatient Clinic 2014–18
- Jenny Victoria Tran,
- Mette Brekke,
- Odd Martin Vallersnes
29.04.2021:
Poisoning by a substance of abuse is dangerous in itself as well as a marker for risky substance use behaviour. Cohort studies in Oslo found that mortality was 5–10 times higher than expected 5–20 years after a poisoning by a substance of abuse, and up to 30 times higher after an opioid poisoning (1...
Restructuring in a GP practice during the COVID-19 pandemic – a focus-group study
- Therese Renaa,
- Mette Brekke
01.02.2021:
In emergency preparedness, it is a general principle that crises should be dealt with by those who are closest to the incident and with the same organisational approach as in regular operations (1). The local GP practice is the first point of contact for most patients and plays a strategic role in...
Acute poisoning from substance abuse of benzodiazepines
- Jon Andreas Andersson,
- Mette Brekke,
- Odd Martin Vallersnes
29.06.2020:
The use of benzodiazepines has increased sharply since they were first synthesised in the 1950s, and they have gradually replaced barbiturates and other hypnotic and anti-anxiety drugs (1). In 2008, 6 % of the Norwegian population was prescribed at least one benzodiazepine (2). Since the 1990s, z...
Acute poisoning with gamma-hydroxybutyrate
- Aron C. Aronsen,
- Mette Brekke,
- Odd Martin Vallersnes
29.06.2020:
Gamma-hydroxybutyrate (GHB) and the closely related gamma-butyrolactone (GBL) and 1,4-butanediol (BD) are relatively new intoxicants in Norway. They first appeared in the 1980s (1). In 2014, 1.7 % in the age group 16–30 years reported that they had used GHB one or more times (2). At the main A&E...
What became of solidarity?
- Mette Brekke,
- Torben Wisborg
31.10.2019:
Maintaining a health service characterised by solidarity requires everyone to do their part. Private health insurance schemes run counter to such solidarity. We can be proud of today's health service in Norway. It has been built up over several generations and is funded by the community (1). The...
Are people left behind on the care pathway?
- Mette Brekke
21.01.2019:
Psychiatric care pathways challenge the general practitioner's patient-centred approach. The care pathway has arrived in the mental health service. Three general pathways were implemented as of 1 January this year, after some debate (1–4): pathways for assessment and treatment in the mental health...
What will general practice be like in the future?
- Mette Brekke,
- Ingvild Vatten Alsnes
14.01.2019:
Making predictions is difficult, especially about the future. But how do we want general practice/family medicine to develop? Will doctors and patients continue to meet mainly in person? Probably, but hardly to the same extent as today. In an editorial in the New England Journal of Medicine from...